User profiles for Katie Jeffery
 | Katie JefferyOxford University Hospital NHS Foundation Trust Verified email at burcot.net Cited by 30494 |
Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report
Background Coronavirus disease 2019 (COVID-19) is associated with diffuse lung damage.
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[PDF][PDF] Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum
The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread
rapidly to become globally dominant and has split into a number of sublineages. BA.1 …
rapidly to become globally dominant and has split into a number of sublineages. BA.1 …
Antibody status and incidence of SARS-CoV-2 infection in health care workers
Background The relationship between the presence of antibodies to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains …
syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains …
[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
Candida auris: a review of the literature
A Jeffery-Smith, SK Taori, S Schelenz… - Clinical microbiology …, 2018 - Am Soc Microbiol
The emerging pathogen Candida auris has been associated with nosocomial outbreaks on
five continents. Genetic analysis indicates the simultaneous emergence of separate clades …
five continents. Genetic analysis indicates the simultaneous emergence of separate clades …
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
…, A Howarth, T James, K Jeffery… - The Lancet Infectious …, 2020 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. …
global pandemic in 2020. Testing is crucial for mitigating public health and economic effects. …
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Background Tocilizumab is a monoclonal antibody that binds to the receptor for interleukin (IL)-6,
reducing inflammation, and is commonly used to treat rheumatoid arthritis. We …
reducing inflammation, and is commonly used to treat rheumatoid arthritis. We …
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Background REGEN-COV is a combination of 2 monoclonal antibodies (casirivimab and
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV-2 …
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV-2 …
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
KJM Jeffery, K Usuku, SE Hall… - Proceedings of the …, 1999 - National Acad Sciences
The risk of disease associated with persistent virus infections such as HIV-I, hepatitis B and
C, and human T-lymphotropic virus-I (HTLV-I) is strongly determined by the virus load. …
C, and human T-lymphotropic virus-I (HTLV-I) is strongly determined by the virus load. …
